Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin.
DNA damage produces delayed mitosis (G2/M delay) in proliferating cells, and shortening the delay sensitizes human malignant glioma and medulloblastoma cells to cytotoxic chemotherapy. Although activation of the cyclin-dependent kinase CDC2 mediates G2/M transition in all tumor cells studied to date...
Main Authors: | Janss, A, Maity, A, Tang, C, Muschel, R, Mckenna, W, Sutton, L, Phillips, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2001
|
Similar Items
-
Total synthesis of ḏḻ-camptothecin.
by: Bradley, Joel Chandler.
Published: (2022) -
Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors
by: Roussos, Evanthia T., et al.
Published: (2011) -
Targeting tumor cells by enhancing radiation sensitivity.
by: Mckenna, W, et al.
Published: (2003) -
Abnormal cytokinesis after X-irradiation in tumor cells that override the G2 DNA damage checkpoint.
by: Huang, H, et al.
Published: (2008) -
Recapitulation of Werner syndrome sensitivity to camptothecin by limited knockdown of the WRN helicase/exonuclease
by: Bird, J, et al.
Published: (2012)